Form 4: DaVita CFO Joel Ackerman Exercises Stock Appreciation Rights
SEC Form 4 Filing
Joel Ackerman, CFO and Treasurer of DaVita Inc., exercised stock appreciation rights and sold shares to cover the exercise price and tax obligations on March 6, 2024.
Summary
- On March 6, 2024, Joel Ackerman, CFO and Treasurer of DaVita Inc., exercised 55,000 stock appreciation rights (SARs) at a price of $52.41.
- Ackerman then disposed of 21,408 shares at $134.65 to cover the base price of the SARs exercise.
- Additionally, 17,149 shares were withheld at $134.65 to satisfy tax withholding obligations related to the SARs exercise.
- Following these transactions, Ackerman directly owns 156,803 shares of DaVita Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the exercise of existing stock appreciation rights and a small sale of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 06/20/2019 | Stock Appreciation Rights were granted. |
| 06/20/2022 | 50% of Stock Appreciation Rights vested. |
| 06/20/2023 | Remaining 50% of Stock Appreciation Rights vested. |
| 03/06/2024 | Earliest transaction date: Exercise of Stock Appreciation Rights and sale of shares. |
| 03/08/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.